SARS-CoV-2

Prof. Leonard Foster

Cloud computing support accelerates COVID-19 vaccine improvements

For the last 11 months, UBC biochemistry and molecular biology professor Prof.. Leonard Foster (he/him/his) and his team have been studying how SARS-CoV-2 – the virus responsible for COVID-19 – attacks the human body, in hopes of developing a more targeted vaccine with fewer side effects.

Apr 14, 2021

In cell cultures analyzed in the current study, hrsACE2 inhibited the coronavirus load by a factor of 1,000-5,000. Credit: IMBA/Tibor Kulcsar

Trial drug can significantly block early stages of COVID-19 in engineered human tissues

An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.

Apr 2, 2020

Credit: Unsplash

Pilot clinical trial in China to test UBC researcher’s findings as a targeted therapy for COVID-19 

A University of British Columbia researcher is part of an international team working with a biotechnology company on a pilot clinical trial of a potential new treatment for patients with severe coronavirus infections in China.

Feb 25, 2020